Literature DB >> 27807240

Porcine Epidemic Diarrhea Virus 3C-Like Protease-Mediated Nucleocapsid Processing: Possible Link to Viral Cell Culture Adaptability.

Peera Jaru-Ampornpan1, Juggragarn Jengarn1,2, Asawin Wanitchang1, Anan Jongkaewwattana3.   

Abstract

Porcine epidemic diarrhea virus (PEDV) causes severe diarrhea and high mortality rates in newborn piglets, leading to massive losses to the swine industry worldwide during recent epidemics. Intense research efforts are now focusing on defining viral characteristics that confer a growth advantage, pathogenicity, or cell adaptability in order to better understand the PEDV life cycle and identify suitable targets for antiviral or vaccine development. Here, we report a unique phenomenon of PEDV nucleocapsid (N) cleavage by the PEDV-encoded 3C-like protease (3Cpro) during infection. The identification of the 3Cpro cleavage site at the C terminus of N supported previous observations that PEDV 3Cpro showed a substrate requirement slightly different from that of severe acute respiratory syndrome coronavirus (SARS-CoV) 3Cpro and revealed a greater flexibility in its substrate recognition site. This cleavage motif is present in the majority of cell culture-adapted PEDV strains but is missing in emerging field isolates. Remarkably, reverse-genetics-derived cell culture-adapted PEDVAVCT12 harboring uncleavable N displayed growth retardation in Vero E6-APN cells compared to the wild-type virus. These observations altogether shed new light on the investigation and characterization of the PEDV nucleocapsid protein and its possible link to cell culture adaptation. IMPORTANCE: Recurrent PEDV outbreaks have resulted in enormous economic losses to swine industries worldwide. To gain the upper hand in combating this disease, it is necessary to understand how this virus replicates and evades host immunity. Characterization of viral proteins provides important clues to mechanisms by which viruses survive and spread. Here, we characterized an intriguing phenomenon in which the nucleocapsids of some PEDV strains are proteolytically processed by the virally encoded main protease. Growth retardation in recombinant PEDV carrying uncleavable N suggests a replication advantage provided by the cleavage event, at least in the cell culture system. These findings may direct us to a more complete understanding of PEDV replication and pathogenicity.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  3C-like protease; cell adaptation; nucleocapsid; porcine epidemic diarrhea virus

Mesh:

Substances:

Year:  2017        PMID: 27807240      PMCID: PMC5215342          DOI: 10.1128/JVI.01660-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Genetic manipulation of porcine epidemic diarrhoea virus recovered from a full-length infectious cDNA clone.

Authors:  Juggragarn Jengarn; Phonphimon Wongthida; Nanchaya Wanasen; Phanramphoei Namprachan Frantz; Asawin Wanitchang; Anan Jongkaewwattana
Journal:  J Gen Virol       Date:  2015-05-15       Impact factor: 3.891

3.  Role of proteases in the release of porcine epidemic diarrhea virus from infected cells.

Authors:  Kazuya Shirato; Shutoku Matsuyama; Makoto Ujike; Fumihiro Taguchi
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

4.  Viral replicase gene products suffice for coronavirus discontinuous transcription.

Authors:  V Thiel; J Herold; B Schelle; S G Siddell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO.

Authors:  Dang Wang; Liurong Fang; Yanling Shi; Huan Zhang; Li Gao; Guiqing Peng; Huanchun Chen; Kui Li; Shaobo Xiao
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

7.  X-Ray Structure and Inhibition of 3C-like Protease from Porcine Epidemic Diarrhea Virus.

Authors:  Sarah E St John; Brandon J Anson; Andrew D Mesecar
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

8.  Isolation and characterization of a Korean porcine epidemic diarrhea virus strain KNU-141112.

Authors:  Sunhee Lee; Youngnam Kim; Changhee Lee
Journal:  Virus Res       Date:  2015-07-18       Impact factor: 3.303

Review 9.  The coronavirus nucleocapsid is a multifunctional protein.

Authors:  Ruth McBride; Marjorie van Zyl; Burtram C Fielding
Journal:  Viruses       Date:  2014-08-07       Impact factor: 5.048

10.  Experimental infection of a US spike-insertion deletion porcine epidemic diarrhea virus in conventional nursing piglets and cross-protection to the original US PEDV infection.

Authors:  Chun-Ming Lin; Thavamathi Annamalai; Xinsheng Liu; Xiang Gao; Zhongyan Lu; Mohamed El-Tholoth; Hui Hu; Linda J Saif; Qiuhong Wang
Journal:  Vet Res       Date:  2015-11-20       Impact factor: 3.683

View more
  13 in total

1.  Caspase-mediated cleavage of nucleocapsid protein of a protease-independent porcine epidemic diarrhea virus strain.

Authors:  Changin Oh; Yunjeong Kim; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2020-05-18       Impact factor: 3.303

2.  Porcine Deltacoronavirus nsp5 Antagonizes Type I Interferon Signaling by Cleaving STAT2.

Authors:  Xinyu Zhu; Dang Wang; Junwei Zhou; Ting Pan; Jiyao Chen; Yuting Yang; Mengting Lv; Xu Ye; Guiqing Peng; Liurong Fang; Shaobo Xiao
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading Viral Nucleocapsid Protein and Activating Type I Interferon Signaling.

Authors:  Sujie Dong; Ning Kong; Yu Zhang; Youwen Li; Dage Sun; Wenzhen Qin; Huanjie Zhai; Xueying Zhai; Xinyu Yang; Chenqian Ye; Manqing Ye; Changlong Liu; Lingxue Yu; Hao Zheng; Wu Tong; Hai Yu; Wen Zhang; Guangzhi Tong; Tongling Shan
Journal:  J Virol       Date:  2022-05-02       Impact factor: 6.549

4.  Trypsin-independent porcine epidemic diarrhea virus US strain with altered virus entry mechanism.

Authors:  Yunjeong Kim; Changin Oh; Vinay Shivanna; Richard A Hesse; Kyeong-Ok Chang
Journal:  BMC Vet Res       Date:  2017-11-25       Impact factor: 2.741

Review 5.  The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.

Authors:  David G Maranon; John R Anderson; Abril G Maranon; Jeffrey Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-07-07       Impact factor: 9.957

6.  Growth enhancement of porcine epidemic diarrhea virus (PEDV) in Vero E6 cells expressing PEDV nucleocapsid protein.

Authors:  Benjamas Liwnaree; Jaraspim Narkpuk; Suttipun Sungsuwan; Anan Jongkaewwattana; Peera Jaru-Ampornpan
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

7.  Porcine epidemic diarrhea virus S1 protein is the critical inducer of apoptosis.

Authors:  Yifeng Chen; Zhibang Zhang; Jie Li; Yueyi Gao; Lei Zhou; Xinna Ge; Jun Han; Xin Guo; Hanchun Yang
Journal:  Virol J       Date:  2018-11-07       Impact factor: 4.099

8.  PEDV nsp16 negatively regulates innate immunity to promote viral proliferation.

Authors:  Peidian Shi; Yanxin Su; Ruiqiao Li; Zhixuan Liang; Shuren Dong; Jinhai Huang
Journal:  Virus Res       Date:  2019-03-05       Impact factor: 3.303

9.  Caspase-mediated cleavage of nucleocapsid protein of a protease-independent porcine epidemic diarrhea virus strain.

Authors:  Changin Oh; Yunjeong Kim; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2020-05-18       Impact factor: 3.303

10.  Nucleocapsid proteins from other swine enteric coronaviruses differentially modulate PEDV replication.

Authors:  Suttipun Sungsuwan; Anan Jongkaewwattana; Peera Jaru-Ampornpan
Journal:  Virology       Date:  2019-11-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.